GlassScriptPhysician profile
James P Wilson
NPI 1952377129
$420.57
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $34.92 · 2021: $170 · 2022: $38.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $66.07 | 2020-2021 | |
| Amgen INC. | $65.21 | 2019-2021 | |
| Lilly USA, LLC | $40.21 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $38.32 | 2022 | |
| Merck Sharp & Dohme LLC | $25.55 | 2019 | |
| Avanir Pharmaceuticals, INC. | $23.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.24 | 2019 | |
| Medtronic Minimed, INC. | $22.17 | 2019 | |
| Abbott Laboratories | $18.31 | 2021 | |
| Jazz Pharmaceuticals INC. | $16.64 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.92 | 2019 | |
| Clarus Therapeutics INC. | $15.78 | 2021 | |
| Novo Nordisk INC | $13.99 | 2019 | |
| Abbvie INC. | $12.66 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.16 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11.75 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.